1-CYCLOPROPYL-6,7,8-TRIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID, 97.0%, 25g

HPLC column NUCLEODUR® NH2 5 µm, 125 mm, 4.6 mm, 1 Piece(s)

5-Bromopyrazolo[1,5-a]pyridine, 95.0%, 10g

1-(3-Chlorophenyl)-2-methyl-2-propanol, 97.0%, 250mg

1-Butyl-3-methylimidazolium hydroxide, 70%, 100g

8-bromo-N,N-dimethyl-1,6-naphthyridin-5-amine, 95.0%, 250mg

4-(1H-Benzo[d][1,2,3]triazol-1-yl)butanoic acid, 98.0%, 5g

3-Chloro-2-methyl-1-propene (stabilized with Stearyl 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionate)>98.0%(GC)25mL

Diosmin, min. 95%, 5 g, glass packaging

2-Bromo-3,4-dihydroxybenzaldehyde, 98%, 250mg

Ultrasonic device Mini 1 Piece

1-(4-Methoxybenzyl)-1H-pyrazol-5-amine, 95.0%, 10g

3-([1,1'-Biphenyl]-4-yl)-2-aminopropanoic acid, 95.0%, 5g